Literature DB >> 8737243

Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen.

A Hara1, K Uemura, T Taketomi.   

Abstract

Sulfatides (galactosylceramide I3-sulfate), which are found in serum lipoproteins of various mammals, effectively increased prothrombin time (anticoagulant effect) and also effectively prolonged bleeding time (anti-platelet effect). When equal volumes of a homogeneous micellar solution of sulfatide and fibrinogen in phosphate-buffered saline were mixed, an insoluble complex precipitated. Analysis of the precipitated complex showed that the molar ratio of sulfatide to fibrinogen was about 400:1. These results indicate that the sulfatide micelle binds tightly to fibrinogen and thereby interferes with both fibrin gel formation (anticoagulant activity) and platelet function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737243     DOI: 10.1007/bf00731493

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  28 in total

1.  The determination of sugar in blood and spinal fluid with anthrone reagent.

Authors:  J H ROE
Journal:  J Biol Chem       Date:  1955-01       Impact factor: 5.157

2.  Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome.

Authors:  T Nishino; Y Aizu; T Nagumo
Journal:  Thromb Res       Date:  1991-06-15       Impact factor: 3.944

3.  Activation of bovine factor XII (Hageman factor) by plasma kallikrein.

Authors:  K Fujikawa; R L Heimark; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1980-04-01       Impact factor: 3.162

Review 4.  New insights into the mechanisms of platelet adhesion and aggregation.

Authors:  Z M Ruggeri
Journal:  Semin Hematol       Date:  1994-07       Impact factor: 3.851

5.  Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit.

Authors:  A Hara; T Taketomi
Journal:  J Biochem       Date:  1991-06       Impact factor: 3.387

6.  The existence of galactosylceramide I3-sulfate in serums of various mammals and its anticoagulant activity.

Authors:  X H Zhu; A Hara; T Taketomi
Journal:  J Biochem       Date:  1991-08       Impact factor: 3.387

7.  The autoactivation of factor XII in the presence of long-chain saturated fatty acids--a comparison with the potency of sulphatides and dextran sulphate.

Authors:  K A Mitropoulos; M P Esnouf
Journal:  Thromb Haemost       Date:  1991-10-01       Impact factor: 5.249

8.  Anticoagulant activity of sulfatide and its anti-thrombotic effect in rabbit.

Authors:  A Hara; Y Kutsukake; K I Uemura; T Taketomi
Journal:  J Biochem       Date:  1993-06       Impact factor: 3.387

9.  Bleeding time in rats: a comparison of different experimental conditions.

Authors:  E Dejana; S Villa; G de Gaetano
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

10.  In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E.

Authors:  Y Hojima; C G Cochrane; R C Wiggins; K F Austen; R L Stevens
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

View more
  9 in total

Review 1.  Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor.

Authors:  N Taniguchi; S Ihara; T Saito; E Miyoshi; Y Ikeda; K Honke
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.

Authors:  M Kyogashima; J Onaya; A Hara; T Taketomi
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

3.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

4.  Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.

Authors:  Lixuan Wang; Yuji Kamijo; Akihiro Matsumoto; Takero Nakajima; Makoto Higuchi; Reiji Kannagi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Glycoconj J       Date:  2011-04-19       Impact factor: 2.916

5.  Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system.

Authors:  M Kyogashima; T Sakai; J Onaya; A Hara
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

6.  Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.

Authors:  Takero Nakajima; Yuji Kamijo; Huang Yuzhe; Takefumi Kimura; Naoki Tanaka; Eiko Sugiyama; Kozo Nakamura; Mamoru Kyogashima; Atsushi Hara; Toshifumi Aoyama
Journal:  Glycoconj J       Date:  2012-10-13       Impact factor: 2.916

7.  Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

Authors:  Rui Hu; Gang Li; Yuji Kamijo; Toshifumi Aoyama; Takero Nakajima; Teruo Inoue; Koichi Node; Reiji Kannagi; Mamoru Kyogashima; Atsushi Hara
Journal:  Glycoconj J       Date:  2007-07-27       Impact factor: 2.916

8.  Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.

Authors:  Hiroki Kanbe; Yuji Kamijo; Takero Nakajima; Naoki Tanaka; Eiko Sugiyama; Lixuan Wang; Zhong-Ze Fang; Atsushi Hara; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Arch Toxicol       Date:  2013-09-25       Impact factor: 5.153

9.  Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study.

Authors:  Makoto Harada; Takero Nakajima; Yosuke Yamada; Daiki Aomura; Akinori Yamaguchi; Kosuke Sonoda; Naoki Tanaka; Koji Hashimoto; Yuji Kamijo
Journal:  J Clin Med       Date:  2022-01-30       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.